tiprankstipranks
Advertisement
Advertisement

MGTX Stock Latest News

MeiraGTx Shareholders Back Board Slate and Auditor Renewal
Company AnnouncementsMeiraGTx Shareholders Back Board Slate and Auditor Renewal
18d ago
8K
MGTX
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe Fly
Acting FDA head vows to block political interference, Endpoint News says
29d ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
1M ago
AZN
BMY
MeiraGTx: Buy Rating Reiterated as Pivotal AQUAx2 Path and Dual Launch Opportunities Support Unchanged $20 Price Target
PremiumRatings
MeiraGTx: Buy Rating Reiterated as Pivotal AQUAx2 Path and Dual Launch Opportunities Support Unchanged $20 Price Target
1M ago
MGTX
MeiraGTx reports Q1 EPS (57c), consensus (45c)
PremiumThe Fly
MeiraGTx reports Q1 EPS (57c), consensus (45c)
2M ago
MGTX
FDA Commissioner Marty Makary resigns
PremiumThe FlyFDA Commissioner Marty Makary resigns
2M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
2M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
2M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
2M ago
DYN
RNA
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
PremiumCompany Announcements
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
2M ago
8K
MGTX
MeiraGTx price target raised to $30 from $26 at Piper Sandler
PremiumThe Fly
MeiraGTx price target raised to $30 from $26 at Piper Sandler
2M ago
JNJ
MGTX
MeiraGTx price target raised to $24 from $16 at RBC Capital
PremiumThe Fly
MeiraGTx price target raised to $24 from $16 at RBC Capital
3M ago
MGTX
MeiraGTx Announces Public Equity Offering to Fund Growth
PremiumCompany AnnouncementsMeiraGTx Announces Public Equity Offering to Fund Growth
3M ago
8K
MGTX
MeiraGTx announces three-year data from Phase 1 AQUAx study
Premium
The Fly
MeiraGTx announces three-year data from Phase 1 AQUAx study
3M ago
MGTX
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
Premium
The Fly
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
3M ago
JNJ
MGTX
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
PremiumCompany Announcements
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
3M ago
8K
MGTX
MeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
PremiumCompany Announcements
MeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
3M ago
8K
MGTX
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
3M ago
DYN
RNA
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
PremiumThe Fly
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
3M ago
MGTX
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
PremiumCompany AnnouncementsMeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
3M ago
MGTX
MeiraGTx price target lowered to $26 from $30 at Piper Sandler
Premium
The Fly
MeiraGTx price target lowered to $26 from $30 at Piper Sandler
3M ago
MGTX
MeiraGTx price target raised to $16 from $14 at BofA
Premium
The Fly
MeiraGTx price target raised to $16 from $14 at BofA
3M ago
MGTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >